MDS sells clinical trial services unit to Ricerca Biosciences

02/10/2010 | Reuters

MDS on Wednesday announced that Ricerca Biosciences has agreed to acquire its clinical trial services business for $45 million and some minority equity interests. MDS said the sale of the unit will complete its divestitures plan and allow the company to focus on Nordion, its medical isotope business.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX